Dapagliflozin (DAPA) Effects in HFpEF

NCT04730947 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

Mayo Clinic